Tokyo Ohka Kogyo Future Growth
Future criteria checks 3/6
Tokyo Ohka Kogyo is forecast to grow earnings and revenue by 15.6% and 8.6% per annum respectively. EPS is expected to grow by 15.8% per annum. Return on equity is forecast to be 12% in 3 years.
Key information
15.6%
Earnings growth rate
15.8%
EPS growth rate
Chemicals earnings growth | 12.9% |
Revenue growth rate | 8.6% |
Future return on equity | 12.0% |
Analyst coverage | Good |
Last updated | 14 Aug 2024 |
Recent future growth updates
Recent updates
Earnings Beat: Here's What Tokyo Ohka Kogyo Co., Ltd. (TSE:4186) Analysts Are Forecasting For This Year
Aug 09The Price Is Right For Tokyo Ohka Kogyo Co., Ltd. (TSE:4186) Even After Diving 33%
Aug 06We Think Tokyo Ohka Kogyo (TSE:4186) Can Stay On Top Of Its Debt
Jul 11Returns Are Gaining Momentum At Tokyo Ohka Kogyo (TSE:4186)
Jun 07Estimating The Fair Value Of Tokyo Ohka Kogyo Co., Ltd. (TSE:4186)
Apr 19Investors Appear Satisfied With Tokyo Ohka Kogyo Co., Ltd.'s (TSE:4186) Prospects As Shares Rocket 34%
Feb 27Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 231,636 | 27,162 | 19,727 | 35,093 | 15 |
12/31/2025 | 212,621 | 23,747 | 16,136 | 29,873 | 16 |
12/31/2024 | 195,027 | 19,925 | -4,249 | 24,963 | 10 |
6/30/2024 | 179,332 | 16,500 | 5,194 | 21,766 | N/A |
3/31/2024 | 168,824 | 14,154 | N/A | N/A | N/A |
12/31/2023 | 162,270 | 12,712 | 1,982 | 17,210 | N/A |
9/30/2023 | 163,591 | 11,998 | N/A | N/A | N/A |
6/30/2023 | 168,397 | 15,325 | 4,299 | 18,791 | N/A |
3/31/2023 | 174,298 | 16,880 | N/A | N/A | N/A |
12/31/2022 | 175,434 | 19,693 | 7,541 | 18,991 | N/A |
9/30/2022 | 169,992 | 22,611 | N/A | N/A | N/A |
6/30/2022 | 159,958 | 21,072 | 11,967 | 20,986 | N/A |
3/31/2022 | 148,683 | 19,283 | N/A | N/A | N/A |
12/31/2021 | 140,055 | 17,748 | 11,629 | 19,758 | N/A |
9/30/2021 | 132,023 | 12,916 | N/A | N/A | N/A |
6/30/2021 | 125,190 | 11,686 | 12,902 | 19,451 | N/A |
3/31/2021 | 120,787 | 11,121 | N/A | N/A | N/A |
12/31/2020 | 117,585 | 9,926 | 16,945 | 22,953 | N/A |
9/30/2020 | 114,266 | 8,652 | N/A | N/A | N/A |
6/30/2020 | 111,091 | 7,125 | 5,408 | 18,999 | N/A |
3/31/2020 | 106,842 | 6,099 | N/A | N/A | N/A |
12/31/2019 | 102,820 | 5,410 | -2,176 | 12,743 | N/A |
9/30/2019 | 102,197 | 5,596 | N/A | N/A | N/A |
6/30/2019 | 103,461 | 6,589 | 4,442 | 11,823 | N/A |
3/31/2019 | 104,237 | 6,750 | N/A | N/A | N/A |
12/31/2018 | 105,277 | 6,875 | 7,586 | 14,311 | N/A |
12/31/2017 | 115,804 | 7,097 | N/A | 13,549 | N/A |
9/30/2017 | 94,918 | 6,961 | N/A | 13,222 | N/A |
6/30/2017 | 93,161 | 6,847 | N/A | N/A | N/A |
3/31/2017 | 88,764 | 6,343 | N/A | 12,476 | N/A |
12/31/2016 | 87,763 | 6,336 | N/A | N/A | N/A |
9/30/2016 | 88,061 | 6,121 | N/A | 11,622 | N/A |
6/30/2016 | 87,632 | 6,519 | N/A | N/A | N/A |
3/31/2016 | 89,969 | 7,716 | N/A | 11,902 | N/A |
12/31/2015 | 91,544 | 8,174 | N/A | N/A | N/A |
9/30/2015 | 90,834 | 8,821 | N/A | 11,904 | N/A |
6/30/2015 | 89,521 | 8,871 | N/A | N/A | N/A |
3/31/2015 | 88,086 | 8,818 | N/A | 13,577 | N/A |
12/31/2014 | 81,665 | 8,957 | N/A | N/A | N/A |
9/30/2014 | 78,255 | 8,719 | N/A | 13,588 | N/A |
6/30/2014 | 77,169 | 8,138 | N/A | N/A | N/A |
3/31/2014 | 75,269 | 7,549 | N/A | 11,881 | N/A |
12/31/2013 | 75,091 | 6,912 | N/A | N/A | N/A |
9/30/2013 | 75,336 | 6,327 | N/A | 12,248 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4186's forecast earnings growth (15.6% per year) is above the savings rate (0.3%).
Earnings vs Market: 4186's earnings (15.6% per year) are forecast to grow faster than the JP market (8.5% per year).
High Growth Earnings: 4186's earnings are forecast to grow, but not significantly.
Revenue vs Market: 4186's revenue (8.6% per year) is forecast to grow faster than the JP market (4.3% per year).
High Growth Revenue: 4186's revenue (8.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4186's Return on Equity is forecast to be low in 3 years time (12%).